Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -3.33 is in line with its 5-year average of -3.03, near the low end of its 5-year range (-3.95–-1.24).
2.63% above its 12-month average of -3.42.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.08.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-3.33
EARNINGS PER SHARE (EPS) AVG TTM
-3.42
EARNINGS PER SHARE (EPS) AVG 3Y
-3.51
EARNINGS PER SHARE (EPS) AVG 5Y
-3.03
EARNINGS PER SHARE (EPS) AVG 10Y
-2.52
EARNINGS PER SHARE (EPS) AVG 15Y
-1.66
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.63%
CURRENT VS 3Y AVG
+4.99%
CURRENT VS 5Y AVG
-9.84%
CURRENT VS 10Y AVG
-32.24%
CURRENT VS 15Y AVG
-100.43%
CURRENT VS 20Y AVG
N/A
Dyne Therapeutics, Inc.
Market Cap
$2.88B
Earnings Per Share (EPS)
-3.33
TTM Avg
-3.42
3Y Avg
-3.51
5Y Avg
-3.03
Market Cap
$2.87B
Earnings Per Share (EPS)
3.86
TTM Avg
3.33
3Y Avg
1.17
5Y Avg
0.32
Market Cap
$2.87B
Earnings Per Share (EPS)
0.21
TTM Avg
-0.59
3Y Avg
-0.72
5Y Avg
-0.48
Market Cap
$2.69B
Earnings Per Share (EPS)
1.26
TTM Avg
1.10
3Y Avg
0.11
5Y Avg
-0.77
Market Cap
$2.69B
Earnings Per Share (EPS)
-12.45
TTM Avg
-4.69
3Y Avg
-1.64
5Y Avg
-2.01
Market Cap
$3.09B
Earnings Per Share (EPS)
-1.41
TTM Avg
-2.98
3Y Avg
-2.05
5Y Avg
-1.75
Market Cap
$2.64B
Earnings Per Share (EPS)
N/A
TTM Avg
-0.45
3Y Avg
-0.45
5Y Avg
-0.45
Market Cap
$2.64B
Earnings Per Share (EPS)
-0.86
TTM Avg
-2.70
3Y Avg
-2.81
5Y Avg
-3.40
Market Cap
$3.15B
Earnings Per Share (EPS)
0.21
TTM Avg
-0.65
3Y Avg
-2.68
5Y Avg
-3.12
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.88B | -3.33 | -3.42 | -3.51 | -3.03 |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 3.86 | 3.33 | 1.17 | 0.32 |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 0.21 | -0.59 | -0.72 | -0.48 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 1.26 | 1.10 | 0.11 | -0.77 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | -12.45 | -4.69 | -1.64 | -2.01 |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | -1.41 | -2.98 | -2.05 | -1.75 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.64B | N/A | -0.45 | -0.45 | -0.45 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -0.86 | -2.70 | -2.81 | -3.40 |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | 0.21 | -0.65 | -2.68 | -3.12 |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | -2.84 | -2.77 | -2.30 | -1.82 |
Trailing EPS (TTM)
$-3.33
Forward EPS (Est.)
$-3.63
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.47 |
| 2024-12-31 | -3.37 |
| 2023-12-31 | -3.95 |
| 2022-12-31 | -3.23 |
| 2021-12-31 | -2.93 |
| 2020-12-31 | -1.24 |
| 2019-12-31 | -0.30 |
| 2018-12-31 | -0.47 |
| 2017-12-31 | 0.47 |
| 2016-12-31 | -9.61 |
| 2015-12-31 | 0.40 |
| 2014-12-31 | -0.53 |
| 2013-12-31 | -3.56 |
| 2012-12-31 | 0.87 |
| 2011-12-31 | -13.48 |
| 2010-12-31 | -1.95 |
| 2009-12-31 | -1.25 |
| 2008-12-31 | 0.20 |
| 2007-12-31 | 0.25 |
